Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome.

Pituitary · 2021 · PMC7864823 · PMID 33216275

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

nominally significantP < 0.05actually significant

To be nominally significant (at P < 0.05) at Month 6, a mean decrease in the total score of − 0.94, representing a relative reduction in the mean score of 22%, would have been required, whereas a reduction of − 0.8 was observed.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.